MetLife shares fell 3.1% after the earnings release, despite record adjusted EPS, as the quarter’s 22% EPS growth was meaningfully supported by $720 million of variable investment income, including stronger private-equity returns. That reliance on market-sensitive gains—and weaker conditions in Chile—may have tempered the reception to management’s upbeat framing.
MetLife's stock edged up modestly by 1.6%, reflecting steady execution but lacking a clear catalyst to drive stronger investor enthusiasm amid mixed segment performance and cautious outlook signals.
Shares declined 2.6% after earnings as investors appeared cautious despite solid top-line growth and resilient margins, likely reflecting concerns around segments with margin pressures and flat to modestly mixed capital market impacts.
MetLife delivered strong third-quarter results, with adjusted earnings rising 22% year-over-year to $1.6 billion, driven by robust investment margins and operational efficiencies.